GM-CSF primes cardiac inflammation in a mouse model of Kawasaki disease

Journal of Experimental Medicine

Volumn 213, Issue 10, 2016, Pages 1983-1998

  Stock, Angus T ^a   Hansen, Jacinta A ^a   Sleeman, Matthew A ^b   McKenzie, Brent S ^c   Wicks, Ian P ^a,d,e  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b MEDIMMUNE   (United States)

^c CSL LIMITED   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; THYMUS AND ACTIVATION REGULATED CHEMOKINE; CHEMOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC VASCULITIS; CARDITIS; CELL COMPARTMENTALIZATION; CONFOCAL MICROSCOPY; FLOW CYTOMETRY; HEART; HEART DISEASE; HEART FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; MACROPHAGE; MONOCYTE; MOUSE; MOUSE MODEL; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULITIS; ANIMAL; ANTIBODY SPECIFICITY; C57BL MOUSE; CANDIDA ALBICANS; CARDIAC MUSCLE; COMPLICATION; DEFICIENCY; DISEASE MODEL; FIBROBLAST; GENETICS; HEMATOPOIESIS; INFLAMMATION; KINETICS; METABOLISM; PATHOLOGY; RADIATION TOLERANCE; SIGNAL TRANSDUCTION;

ANIMALS; CANDIDA ALBICANS; CELL COMPARTMENTATION; CHEMOKINES; DISEASE MODELS, ANIMAL; FIBROBLASTS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIESIS; INFLAMMATION; KINETICS; MICE, INBRED C57BL; MONOCYTES; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYOCARDIUM; NEUTROPHILS; ORGAN SPECIFICITY; RADIATION TOLERANCE; SIGNAL TRANSDUCTION; VASCULITIS;

EID: 84992170429     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20151853     Document Type: Article

References (54)

1. Beiser, A.S., M. Takahashi, A.L. Baker, R.P. Sundel, and J.W. Newburger. US Multicenter Kawasaki Disease Study Group. 1998. A predictive instrument for coronary artery aneurysms in Kawasaki disease. Am. J. Cardiol. 81:1116-1120. http://dx.doi.org/10.1016/S0002-9149(98)00116-7
2. Biezeveld, M.H., G. van Mierlo, R. Lutter, I.M. Kuipers, T. Dekker, C.E. Hack, J.W. Newburger, and T.W. Kuijpers. 2005. Sustained activation of neutrophils in the course of Kawasaki disease: an association with matrix metalloproteinases. Clin. Exp. Immunol. 141:183-188. http://dx.doi.org/10.1111/j.1365-2249.2005.02829.x
3. Brown, T.J., S.E. Crawford, M.L. Cornwall, F. Garcia, S.T. Shulman, and A.H. Rowley. 2001. CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease. J. Infect. Dis. 184:940-943. http://dx.doi.org/10.1086/323155
4. Burns, J.C., E.V. Capparelli, J.A. Brown, J.W. Newburger, and M.P. Glode. US/Canadian Kawasaki Syndrome Study Group. 1998. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. Pediatr. Infect. Dis. J. 17:1144-1148. http://dx.doi.org/10.1097/00006454-199812000-00009
5. Campbell, I.K., A. van Nieuwenhuijze, E. Segura, K. O'Donnell, E. Coghill, M. Hommel, S. Gerondakis, J.A. Villadangos, and I.P. Wicks. 2011. Differentiation of inflammatory dendritic cells is mediated by NF-κB1-dependent GM-CSF production in CD4 T cells. J. Immunol. 186:5468-5477. http://dx.doi.org/10.4049/jimmunol.1002923
6. Codarri, L., G. Gyülvészi, V. Tosevski, L. Hesske, A. Fontana, L. Magnenat, T. Suter, and B. Becher. 2011. RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 12:560-567. http://dx.doi.org/10.1038/ni.2027
7. Cornish, A.L., I.K. Campbell, B.S. McKenzie, S. Chatfield, and I.P. Wicks. 2009. G-CSF and GM-CSF as therapeutic targets in rheumatoid arthritis. Nat. Rev. Rheumatol. 5:554-559. http://dx.doi.org/10.1038/nrrheum.2009.178
8. + monocytes and licenses autoimmunity. Immunity. 43:502-514. http://dx.doi.org/10.1016/j.immuni.2015.08.010
9. Dahdah, N. 2010. Not just coronary arteritis, Kawasaki disease is a myocarditis, too. J. Am. Coll. Cardiol. 55:1507. http://dx.doi.org/10.1016/j.jacc.2009.11.067
10. Epelman, S., K.J. Lavine, A.E. Beaudin, D.K. Sojka, J.A. Carrero, B. Calderon, T. Brija, E.L. Gautier, S. Ivanov, A.T. Satpathy, et al. 2014a. Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity. 40:91-104. http://dx.doi.org/10.1016/j.immuni.2013.11.019
11. Epelman, S., K.J. Lavine, and G.J. Randolph. 2014b. Origin and functions of tissue macrophages. Immunity. 41:21-35. http://dx.doi.org/10.1016/j.immuni.2014.06.013
12. Fujiwara, H., and Y. Hamashima. 1978. Pathology of the heart in Kawasaki disease. Pediatrics. 61:100-107
13. Fujiwara, H., C. Kawai, and Y. Hamashima. 1978. Clinicopathologic study of the conduction systems in 10 patients with Kawasaki's disease (mucocutaneous lymph node syndrome). Am. Heart J. 96:744-750. http://dx.doi.org/10.1016/0002-8703(78)90007-8
14. Furtado, M.B., M.W. Costa, E.A. Pranoto, E. Salimova, A.R. Pinto, N.T. Lam, A. Park, P. Snider, A. Chandran, R.P. Harvey, et al. 2014. Cardiogenic genes expressed in cardiac fibroblasts contribute to heart development and repair. Circ. Res. 114:1422-1434. http://dx.doi.org/10.1161/CIRCRESAHA.114.302530
15. Furusho, K., T. Kamiya, H. Nakano, N. Kiyosawa, K. Shinomiya, T. Hayashidera, T. Tamura, O. Hirose, Y. Manabe, T. Yokoyama, et al. 1984. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet. 324:1055-1058. http://dx.doi.org/10.1016/S0140-6736(84)91504-6
16. Greven, D.E., E.S. Cohen, D.M. Gerlag, J. Campbell, J. Woods, N. Davis, A. van Nieuwenhuijze, A. Lewis, S. Heasmen, M. McCourt, et al. 2015. Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis. Ann. Rheum. Dis. 74:1924-1930. http://dx.doi.org/10.1136/annrheumdis-2014-205234
17. Hamamichi, Y., F. Ichida, X. Yu, K.I. Hirono, K.I. Uese, I. Hashimoto, S. Tsubata, T. Yoshida, T. Futatani, H. Kanegane, and T. Miyawaki. 2001. Neutrophils and mononuclear cells express vascular endothelial growth factor in acute Kawasaki disease: its possible role in progression of coronary artery lesions. Pediatr. Res. 49:74-80. http://dx.doi.org/10.1203/00006450-200101000-00017
18. Harada, M., Y. Yokouchi, T. Oharaseki, K. Matsui, H. Tobayama, N. Tanaka, K. Akimoto, K. Takahashi, M. Kishiro, T. Shimizu, and K. Takahashi. 2012. Histopathological characteristics of myocarditis in acute-phase Kawasaki disease. Histopathology. 61:1156-1167. http://dx.doi.org/10.1111/j.1365-2559.2012.04332.x
19. Holman, R.C., E.D. Belay, K.Y. Christensen, A.M. Folkema, C.A. Steiner, and L.B. Schonberger. 2010. Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007. Pediatr. Infect. Dis. J. 29:483-488. http://dx.doi.org/10.1097/INF.0b013e3181cf8705
20. Kato, H., T. Sugimura, T. Akagi, N. Sato, K. Hashino, Y. Maeno, T. Kazue, G. Eto, and R. Yamakawa. 1996. Long-term consequences of Kawasaki disease. A 10-to 21-year follow-up study of 594 patients. Circulation. 94:1379-1385. http://dx.doi.org/10.1161/01.CIR.94.6.1379
21. Kawasaki, T. 1967. [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. Arerugi. 16:178-222
22. Kawasaki, T. 2006. Kawasaki disease. Proc. Jpn. Acad., Ser. B, Phys. Biol. Sci. 82:59-71. http://dx.doi.org/10.2183/pjab.82.59
23. Kerscher, B., J.A. Willment, and G.D. Brown. 2013. The Dectin-2 family of C-type lectin-like receptors: an update. Int. Immunol. 25:271-277. http://dx.doi.org/10.1093/intimm/dxt006
24. Ko, H.J., J.L. Brady, V. Ryg-Cornejo, D.S. Hansen, D. Vremec, K. Shortman, Y. Zhan, and A.M. Lew. 2014. GM-CSF-responsive monocyte-derived dendritic cells are pivotal in Th17 pathogenesis. J. Immunol. 192:2202-2209. http://dx.doi.org/10.4049/jimmunol.1302040
25. Korematsu, S., Y. Ohta, N. Tamai, M. Takeguchi, C. Goto, H. Miyahara, T. Kawano, and T. Izumi. 2012. Cell distribution differences of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in patients with Kawasaki disease. Pediatr. Infect. Dis. J. 31:973-974. http://dx.doi.org/10.1097/INF.0b013e31825ba6b3
26. Lavine, K.J., S. Epelman, K. Uchida, K.J. Weber, C.G. Nichols, J.D. Schilling, D.M. Ornitz, G.J. Randolph, and D.L. Mann. 2014. Distinct macrophage lineages contribute to disparate patterns of cardiac recovery and remodeling in the neonatal and adult heart. Proc. Natl. Acad. Sci. USA. 111:16029-16034. http://dx.doi.org/10.1073/pnas.1406508111
27. Lee, C.P., Y.H. Huang, Y.W. Hsu, K.D. Yang, H.C. Chien, H.R. Yu, Y.L. Yang, C.L. Wang, W.C. Chang, and H.C. Kuo. 2013. TARC/CCL17 gene polymorphisms and expression associated with susceptibility and coronary artery aneurysm formation in Kawasaki disease. Pediatr. Res. 74:545-551. http://dx.doi.org/10.1038/pr.2013.134
28. Lee, Y., D.J. Schulte, K. Shimada, S. Chen, T.R. Crother, N. Chiba, M.C. Fishbein, T.J. Lehman, and M. Arditi. 2012. Interleukin-1β is crucial for the induction of coronary artery inflammation in a mouse model of Kawasaki disease. Circulation. 125:1542-1550. http://dx.doi.org/10.1161/CIRCULATIONAHA.111.072769
29. Matsubara, T., S. Furukawa, and K. Yabuta. 1990. Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-γ in Kawasaki disease involved coronary-artery lesions. Clin. Immunol. Immunopathol. 56:29-36. http://dx.doi.org/10.1016/0090-1229(90)90166-N
30. Molawi, K., Y. Wolf, P.K. Kandalla, J. Favret, N. Hagemeyer, K. Frenzel, A.R. Pinto, K. Klapproth, S. Henri, B. Malissen, et al. 2014. Progressive replacement of embryo-derived cardiac macrophages with age. J. Exp. Med. 211:2151-2158. http://dx.doi.org/10.1084/jem.20140639
31. Murata, H., and S. Naoe. 1987. Experimental Candida-induced arteritis in mice-relation to arteritis in Kawasaki disease. Prog. Clin. Biol. Res. 250:523
32. Nagi-Miura, N., T. Harada, H. Shinohara, K. Kurihara, Y. Adachi, A. Ishida-Okawara, T. Oharaseki, K. Takahashi, S. Naoe, K. Suzuki, and N. Ohno. 2006. Lethal and severe coronary arteritis in DBA/2 mice induced by fungal pathogen, CAWS, Candida albicans water-soluble fraction. Atherosclerosis. 186:310-320. http://dx.doi.org/10.1016/j.atherosclerosis.2005.08.014
33. Naoe, S., K. Takahashi, H. Masuda, and N. Tanaka. 1991. Kawasaki disease. With particular emphasis on arterial lesions. Acta Pathol. Jpn. 41:785-797
34. Newburger, J.W., M. Takahashi, J.C. Burns, A.S. Beiser, K.J. Chung, C.E. Duffy, M.P. Glode, W.H. Mason, V. Reddy, S.P. Sanders, et al. 1986. The treatment of Kawasaki syndrome with intravenous gamma globulin. N. Engl. J. Med. 315:341-347. http://dx.doi.org/10.1056/NEJM198608073150601
35. Ng, L.G., J.S. Qin, B. Roediger, Y. Wang, R. Jain, L.L. Cavanagh, A.L. Smith, C.A. Jones, M. de Veer, M.A. Grimbaldeston, et al. 2011. Visualizing the neutrophil response to sterile tissue injury in mouse dermis reveals a three-phase cascade of events. J. Invest. Dermatol. 131:2058-2068. http://dx.doi.org/10.1038/jid.2011.179
36. Niwa, Y., and K. Sohmiya. 1984. Enhanced neutrophilic functions in mucocutaneous lymph node syndrome, with special reference to the possible role of increased oxygen intermediate generation in the pathogenesis of coronary thromboarteritis. J. Pediatr. 104:56-60. http://dx.doi.org/10.1016/S0022-3476(84)80589-2
37. Onouchi, Y. 2012. Genetics of Kawasaki disease: What we know and don't know. Circ. J. 76:1581-1586. http://dx.doi.org/10.1253/circj. CJ-12-0568
38. Onouchi, Y., K. Ozaki, J.C. Burns, C. Shimizu, M. Terai, H. Hamada, T. Honda, H. Suzuki, T. Suenaga, T. Takeuchi, et al. US Kawasaki Disease Genetics Consortium. 2012. A genome-wide association study identifies three new risk loci for Kawasaki disease. Nat. Genet. 44:517-521. http://dx.doi.org/10.1038/ng.2220
39. Principi, N., D. Rigante, and S. Esposito. 2013. The role of infection in Kawasaki syndrome. J. Infect. 67:1-10. http://dx.doi.org/10.1016/j.jinf.2013.04.004
40. Saijo, S., S. Ikeda, K. Yamabe, S. Kakuta, H. Ishigame, A. Akitsu, N. Fujikado, T. Kusaka, S. Kubo, S.H. Chung, et al. 2010. Dectin-2 recognition of a-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans. Immunity. 32:681-691. http://dx.doi.org/10.1016/j.immuni.2010.05.001
41. Senzaki, H. 2006. The pathophysiology of coronary artery aneurysms in Kawasaki disease: role of matrix metalloproteinases. Arch. Dis. Child. 91:847-851. http://dx.doi.org/10.1136/adc.2005.087437
42. Shiomi, A., and T. Usui. 2015. Pivotal roles of GM-CSF in autoimmunity and inflammation. Mediators Inflamm. 2015. http://dx.doi.org/10.1155/2015/568543
43. Sonderegger, I., G. Iezzi, R. Maier, N. Schmitz, M. Kurrer, and M. Kopf. 2008. GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival. J. Exp. Med. 205:2281-2294. http://dx.doi.org/10.1084/jem.20071119
44. Stock, A.T., J.M. Smith, and F.R. Carbone. 2014. Type I IFN suppresses Cxcr2 driven neutrophil recruitment into the sensory ganglia during viral infection. J. Exp. Med. 211:751-759. http://dx.doi.org/10.1084/jem.20132183
45. Sundel, R.P. 2015. Kawasaki disease. Rheum. Dis. Clin. North Am. 41:63-73. http://dx.doi.org/10.1016/j.rdc.2014.09.010
46. Suzuki, H., E. Noda, M. Miyawaki, T. Takeuchi, S. Uemura, and M. Koike. 2001. Serum levels of neutrophil activation cytokines in Kawasaki disease. Pediatr. Int. 43:115-119. http://dx.doi.org/10.1046/j.1442-200x.2001.01362.x
47. Tada, R., N. Nagi-Miura, Y. Adachi, and N. Ohno. 2008. The influence of culture conditions on vasculitis and anaphylactoid shock induced by fungal pathogen Candida albicans cell wall extract in mice. Microb. Pathog. 44:379-388. http://dx.doi.org/10.1016/j.micpath.2007.10.013
48. Takahashi, K., T. Oharaseki, S. Naoe, M. Wakayama, and Y. Yokouchi. 2005. Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease. Pediatr. Int. 47:305-310. http://dx.doi.org/10.1111/j.1442-200x.2005.02049.x
49. Takahashi, K., T. Oharaseki, and Y. Yokouchi. 2011. Pathogenesis of Kawasaki disease. Clin. Exp. Immunol. 164:20-22. http://dx.doi.org/10.1111/j.1365-2249.2011.04361.x
50. Uehara, R., and E.D. Belay. 2012. Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J. Epidemiol. 22:79-85. http://dx.doi.org/10.2188/jea. JE20110131
51. Wicks, I.P., and A.W. Roberts. 2016. Targeting GM-CSF in inflammatory diseases. Nat. Rev. Rheumatol. 12:37-48. http://dx.doi.org/10.1038/nrrheum.2015.161
52. Wu, L., S. Ong, M.V. Talor, J.G. Barin, G.C. Baldeviano, D.A. Kass, D. Bedja, H. Zhang, A. Sheikh, J.B. Margolick, et al. 2014. Cardiac fibroblasts mediate IL-17A-driven inflammatory dilated cardiomyopathy. J. Exp. Med. 211:1449-1464. http://dx.doi.org/10.1084/jem.20132126
53. Yoshimura, K., K. Tatsumi, A. Iharada, S. Tsuji, A. Tateiwa, M. Teraguchi, H. Ogino, and K. Kaneko. 2009. Increased nitric oxide production by neutrophils in early stage of Kawasaki disease. Eur. J. Pediatr. 168:1037-1041. http://dx.doi.org/10.1007/s00431-008-0872-1
54. Zlotnik, A., and O. Yoshie. 2012. The chemokine superfamily revisited. Immunity. 36:705-716. http://dx.doi.org/10.1016/j.immuni.2012.05.008